Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of efficacy and tolerability of different intravenous methylprednisolone doses in active moderate Graves orbitopathy
2006-002555-33Phase 4Active
- Sponsor
- Hospices Civils de Lyon
- Start
- Feb 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylprednisolone in Graves' ophthalmopathy (TED), sponsored by Hospices Civils de Lyon. Primary endpoint: Efficacy. Started Feb 2007; status: active.
02
Drugs
methylprednisolone
03
Conditions
Graves' ophthalmopathy (TED)
Beyond the preview
Go deeper on 2006-002555-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002555-33.